… for the initial and long-term treatment of VTE. Moreover, it would … Excellence indicated that
apixaban could be considered a … efficacy of apixaban in Japanese acute PE/DVT subjects with …

… Randomized, parallel group, warfarin control, multicenter phase II study evaluating safety
of DU-176b in Japanese subjects with non-valvular atrial fibrillation (NVAF). J Thromb …

… -defined major or CRNM bleeding for Japanese subjects is 3.0% in the placebo group and
ranges from 5.7% to 7.9% in the apixaban groups, this sample size provides the precision of …

… Japanese AF patients in our study is slightly lower than that in healthy male Japanese subjects
35… Therefore, the racial and pathological differences among AF patients or subjects were …

Full article: Safety and effectiveness of apixaban in comparison to warfarin in patients with
nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative …

Full article: Pharmacokinetics of anticoagulants apixaban, dabigatran, edoxaban and rivaroxaban
in elderly Japanese patients with atrial fibrillation treated in one general hospital Skip …

… Japanese patients newly initiated on apixaban for treatment of VTE or prevention of recurrent
… treated with apixaban and patients who had received prior treatment with apixaban were …

… On such occasions, sufficient consideration should be given not to include information
which can identify subjects, such as the name of subjects. Furthermore, the data on subjects …

… The risk of any bleeding was significantly lower for apixaban (… Japanese patients with NVAF,
treatment with apixaban 5/2.5 … Treatment with dabigatran 150/110 mg BID or rivaroxaban 15…

… The most frequently reported treatment-emergent AE in this … subjects and one Japanese
subject who received apixaban, as well as one Caucasian subject and one Japanese subject …